UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.    )

 ____________________

Filed by the Registrant  ☒

Filed by a Party other than the Registrant  ☐

Check the appropriate box:

☐   Preliminary Proxy Statement
☐   Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)
☒   Definitive Proxy Statement
☐   Definitive Additional Materials
☐   Soliciting Material under Rule 14a-12

STANDARD PREMIUM FINANCE HOLDINGS, INC.

(Name of the Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒   No fee required.
☐   Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
    1.   Title of each class of securities to which transaction applies:
    2.   Aggregate number of securities to which transaction applies:
    3.   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):
    4.   Proposed maximum aggregate value of transaction:
    5.   Total fee paid:
☐   Fee paid previously with preliminary materials.
☐   Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
    1.   Amount Previously Paid:
    2.   Form, Schedule or Registration Statement No.:
    3.   Filing Party:
    4.   Date Filed:

 

 

 

 
 

 

STANDARD PREMIUM FINANCE HOLDINGS, INC.

13590 SW 134th Avenue,

Suite 214

Miami, FL 33186

Dear Fellow Stockholders:

You are cordially invited to attend the 2023 Annual Meeting of Stockholders of Standard Premium Finance Holdings, Inc. which will be held at Three Lakes Clubhouse, 13321 SW 151st Terrace, Miami, Florida 33186 at 4:00 p.m., Eastern Daylight Time, on Friday, June 23, 2023.

During the meeting, we will conduct the business described in the Notice of Annual Meeting of Stockholders and Proxy Statement. I hope you will be able to attend.

We are following Securities and Exchange Commission rules which enable us to provide proxy materials for the 2023 Annual Meeting on the Internet instead of automatically mailing printed copies. This allows us to provide our stockholders with the information they need, while lowering the cost of the delivery of materials and reducing the environmental impact from printing, mailing and disposing of paper copies. Stockholders of record will receive a notice with instructions on how to access those documents over the internet and request a paper copy of our proxy materials, including this proxy statement, our 2022 Annual Report and voting instructions. Stockholders whose shares are held in a brokerage account will receive this information from their broker.

Whether or not you plan to attend the Annual Meeting, it is important that you vote by following the voting instructions provided by the Company or your broker. If you attend the Annual Meeting and decide to vote in person, you may revoke your proxy.

On behalf of the directors, officers and employees of Standard Premium Finance Holdings, Inc., I thank you for your continued support.

 

   
  Sincerely,
   
  William J. Koppelmann
  Chairman and Chief Executive Officer

May 8, 2023

PLEASE VOTE NOW TO AVOID THE EXPENSE OF A FURTHER SOLICITATION

 

 
 

STANDARD PREMIUM FINANCE HOLDINGS, INC.

13590 SW 134th Avenue,

Suite 214

Miami, FL 33186

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

To Be Held on June 23, 2023

 

The 2023 Annual Meeting of the Stockholders (the “Annual Meeting”) of Standard Premium Finance Holdings, Inc., a Florida corporation (the “Company”), will be held at Three Lakes Clubhouse, 13321 SW 151st Terrace, Miami, Florida 33186 on Friday, June 23, 2023 at 4:00 p.m., Eastern Daylight Time, for the following purposes:

 

1.To elect three (3) members to the Company’s Board of Directors to serve until the 2026 annual meeting of stockholders;

 

2.To ratify the selection of the independent registered public accounting firm for 2023

 

3.To approve the issuance of up to 1,400,000 common stock purchase warrants to company directors, officers and consultants and issuance of up to 1,400,000 shares of common stock upon the exercise of such warrants; and

 

To transact such other business as may properly come before the meeting or any adjournment thereof.

 

Our Board of Directors has fixed the close of business on April 24, 2023 as the record date for the determination of stockholders entitled to notice of and to vote at the meeting or any adjournment thereof.

 

Your attention is directed to the following pages for information on voting and obtaining a paper copy of the proxy materials for the Annual Meeting.

 

You are cordially invited to attend the Annual Meeting. The Board of Directors encourages you to access the proxy materials and vote in person or by proxy by following the instructions on the following pages.

 

   
  By Order of the Board of Directors
   
  Margaret Ruiz
  Secretary

Miami, Florida

May 8, 2023

 

 
 

 

STANDARD PREMIUM FINANCE HOLDINGS, INC.

13590 SW 134th Avenue,

Suite 214

Miami, FL 33186

PROXY STATEMENT

ANNUAL MEETING OF STOCKHOLDERS

To Be Held June 23, 2023

About this Proxy Statement

This Proxy Statement is being made available on or about May 8, 2023 to the holders of common stock (the “common stock”) and Series A Convertible Preferred Stock (the “preferred stock”) of Standard Premium Finance Holdings, Inc. (the “Company”) in connection with the solicitation by the Board of Directors of the Company of proxies for use at the Annual Meeting of Stockholders (the “Annual Meeting”) to be held on June 23, 2023, or at any adjournment thereof. The purposes of the Annual Meeting and the matters to be acted upon are set forth in the accompanying Notice of Annual Meeting of Stockholders. As of the date of this Proxy Statement, the Board of Directors is not aware of any other matters that will come before the Annual Meeting. However, if any other matters properly come before the Annual Meeting, the persons named as proxies will vote on them in accordance with their best judgment.

Voting Instructions for Stockholders of Record

If you hold a stock certificate for shares in your name you are considered a stockholder of record (or registered stockholder) of those shares. You may vote by internet, mail or by attending the Annual Meeting.

Voting on the Internet

 

·Go to: https://www.iproxydirect.com/spfx : enter the 12-digit control number from the Notice Card sent to you in the mail and then follow the on-screen instructions.

Voting by Mail

 

·Download or Request a paper copy of the proxy card as instructed below.
·Return your signed and dated proxy card for receipt by 4:00 p.m., Eastern Daylight Time on June 23, 2023, the time and date of the Annual Meeting.

Voting in Person

 

·You may vote in person at the Annual Meeting, even if you already voted on the internet or by mail and your vote at the meeting will supersede any prior vote.

To Request a Paper Copy of Proxy Materials or Proxy Card for 2023 Annual Meeting of Stockholders:

Stockholders of Record

If you are a stockholder of record and you prefer to receive a paper copy of our proxy materials and/or proxy card, you must request one. There is no charge to you for requesting a copy.

To order a copy of the proxy materials and select a future delivery preference:

Paper copies: Current and future paper delivery requests can be submitted via the telephone, fax, Internet or email options below.

1 
 

 

Email copies: Current and future email delivery requests must be submitted via the Internet following the instructions below.

 

If you request an email copy of current materials you will receive an email with a link to the materials.

 

PLEASE NOTE: You must use the control number in the shaded bar on the reverse side of the notice or proxy card you received when requesting a set of proxy materials.

 

·Internet: Go to https://www.iproxydirect.com/spfx. Follow the instructions to log in and order a copy of the current meeting materials and submit your preference for email or paper delivery of future meeting materials.
·Fax: Send your Notice Card sent to you in the mail to 202-521-3464 via fax. You can also include a preference to receive a paper copy for future meetings by including these instructions in the fax.
·Telephone: Call us free of charge at 1-866-752-8683 and follow the instructions to log in and order a paper copy of the materials by mail for the current meeting. You can also submit a preference to receive a paper copy for future meetings.
·Email: Send email to proxy@iproxydirect.com with “Proxy Materials SPFX” in the subject line. Include in the message your full name and address, plus the 12-digit number located on the Notice Card sent to you in the mail, and state in the email that you want a paper copy of current meeting materials. You can also state your preference to receive a paper copy for future meetings.

 

All requests for a paper copy of the proxy materials must be received by June 2, 2023 to facilitate timely delivery.

 

Instructions for Beneficial Owners of our Shares

 

If your shares are held in a stock brokerage account or other custodial account, you are considered the Beneficial Owner of shares held in street name.

 

Beneficial Owners may view the Proxy Materials on the Internet or Request a Paper Copy of the Proxy Materials or Proxy Card for the Annual Meeting by following the instructions on the Notice Card sent to you by your broker or custodian.

 

Voting Instructions for Beneficial Owners

 

You may vote by internet, fax, telephone, mail or in person by following the instructions on the Notice Card sent to you by your broker or custodian.

 

Instructions for Voting in Person for Beneficial Owners

 

Since you are not a stockholder of record, you may not vote your shares in person at the meeting unless you have a proxy from the bank, broker, trustee or nominee that holds your shares giving you the right as beneficial owner to vote your shares at the meeting. To request a proxy, follow the instructions on the Notice Card sent to you by your broker or custodian.

 

Revocability and Voting of Proxy

 

Any stockholder who gives a proxy may revoke it at any time before it is voted by delivering to the Secretary of the Company a written notice of revocation or a duly executed proxy bearing a later date, or by voting in person at the Annual Meeting. All proxies properly executed and returned will be voted in accordance with the instructions specified thereon. If no instructions are given, proxies will be voted FOR the election of the nominees of the Board of Directors and FOR Proposal No. 2.

 

Record Date, Voting Rights and Quorum

 

Only stockholders of record at the close of business on April 24, 2023 (the “Record Date”) are entitled to notice of and to vote at the Annual Meeting or at any adjournment thereof. At that date there were 2,905,016 shares of Common Stock outstanding and 166,000 shares of Series A Convertible Preferred Stock outstanding. At the Annual Meeting, each issued and outstanding share of Common Stock and Series A Convertible Preferred Stock will be entitled to one vote and will vote a single class. The holders of a majority of the 3,071,016 shares of Common Stock and Series A Convertible Preferred Stock present in person or by proxy and entitled to vote, will constitute a quorum at the Annual Meeting.

 

Proxies marked “withheld” as to any director nominee or “abstain” or “against” as to a particular proposal and broker non-votes will be counted for purposes of determining the presence or absence of a quorum.

 

“Broker non-votes” are shares held by brokers or nominees which are present in person or represented by proxy, but which are not voted on a particular matter because instructions have not been received from the beneficial owner. The effect of proxies marked “withheld” as to any director nominee or “abstain” or “against” as to a particular proposal and broker non-votes on each Proposal is discussed under each respective Proposal.

 

2 
 

 

PROPOSAL NO. 1

ELECTION OF DIRECTORS

 

The Company’s Bylaws established a tiered Board of Directors in 2020 which will result in three tiers of directors, with each tier of directors serving three-year terms that will end in successive years beginning at the 2023 annual meeting of stockholders. The Company currently has eight directors. Tier I currently consists of two directors who were elected at the 2022 Annual Meeting to serve until the 2024 annual meeting of stockholders of the Company or until their successors are duly elected and qualified. Tier II currently consists of three directors who were elected at the 2022 Annual Meeting to hold office until the 2025 annual meeting of stockholders of the Company or until their successors are duly elected and qualified. Tier III currently consists of three directors who will be elected at the 2023 Annual Meeting to hold office until the 2026 annual meeting of stockholders of the Company or until their successors are duly elected and qualified.

 

Unless otherwise instructed, the proxy holders named in the enclosed proxy will vote the proxies received by them for the three nominees of the Board of Directors named below.

 

Each nominee of the Board of Directors has indicated that he is willing and able to serve as director if elected. If any nominee of the Board of Directors becomes unavailable for any reason before the election, proxies will be voted for the election of such substitute nominee or nominees, if any, as shall be designated by the Board of Directors. The Board of Directors has no reason to believe that any of the nominees will be unavailable to serve.

 

Vote Required

 

The nominees who receive the highest number of affirmative votes of the shares present in person or represented by proxy and entitled to vote, a quorum being present, shall be elected as directors. Only votes cast “FOR” a nominee will be counted, except that the accompanying proxy will be voted “FOR” all nominees in the absence of instructions to the contrary. Broker non-votes and proxies marked “withheld” as to one or more nominees will have no effect on the election since only votes “FOR” a nominee are counted in order to determine the three nominees with the highest number of votes.

 

The directors being nominated for election to the Board of Directors (each, a “Nominee”) at the 2023 Annual Meeting and the directors who will continue to serve on the Board of Directors until the 2024 and 2025 annual meeting, their positions and offices held with the Company and certain biographical information are set forth below.

 

Name   Positions Held with the Company
     
Director Nominees whose terms expire at the 2023 annual meeting of stockholders:
William Koppelmann   Director, Chairman, President and Chief Executive Officer
Mark Kutner, MD   Director
Scott Howell, MD   Director
     
Directors whose term will expire at the 2024 annual meeting of stockholders:
Brian Krogol   Chief Financial Officer, Director
James Wall   Director
     
Directors whose terms will expire at the 2025 annual meeting of stockholders:
John Leavitt   Director
Christopher Perrucci   Director
Carl Hoechner   Director

 

 

3 
 

 

THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE “FOR” THE ELECTION OF EACH OF THE NOMINEES NAMED BELOW.

 

Nominees of the Board of Directors

 

The following three nominees, all of whom are current directors of the Company, are the nominees of the Board of Directors for election at the 2023 Annual Meeting. Certain information about the nominees, including their experience, qualifications and, attributes or skills that led the Board to conclude that the nominees should continue to serve as directors of the Company is set forth below.

 

Director Nominees whose term will expire at the 2026 annual meeting of stockholders:

William Koppelmann – Chairman, Board of Directors, President and Chief Executive Officer.

 

William Koppelmann, age 60, has been the Chairman and President of Standard Premium Finance Holdings, Inc., since its organization in May 2017 and is a co-founder and has been the President of Standard Premium Finance Management Corporation, since its inception in 1997. An entrepreneur with more than 30 years’ experience in the insurance premium finance industry, he is proficient in receivables management, capital-raising and debt restructuring. He currently oversees all aspects of the Company's operations. Mr. Koppelmann has served on the board of the Florida Premium Finance Association for more than 15 years. He is the immediate past president, serving in that capacity for three successive terms. Mr. Koppelmann attended Barry University and Miami Dade College, where he completed his Property and Casualty insurance Certification. He is a member of the Florida Association of Insurance Agents, Professional Insurance Agents Association, Latin American Insurance Association and Independent Insurance Agents of Dade County. William Koppelmann is Margaret Ruiz’s brother. The Board believes that Mr. Koppelmann provides essential insight and expertise concerning the business, operations and strategies of the Company that is needed for the Board’s oversight and decision-making responsibilities.

 

Mark E. Kutner, MD – Director.

 

Dr. Mark E. Kutner, age 62, has been a Director of Holdings since its foundation in 2017. Dr. Mark E. Kutner is a practicing physician who maintains a primary care clinical practice in Miami, Florida, which he began in 1998, and a clinical trials practice begun in 1988. Dr. Kutner is a co-founder and presently the Chairman of the Board of Directors of PrimeHealth Physicians, the largest independent primary care practice in South Florida. Dr. Kutner was the founder and is presently Chief Medical Officer of Suncoast Research Group, a clinical trials company since 1994, which has been engaged in phases, 2, 3 and 4 clinical trials for many of the largest pharmaceutical companies in the world and smaller biotech firms who are constantly developing cutting edge medical technologies. He served on the Board of Directors of Orange ACO, a rapidly growing Medicare ACO from 2015-2018. Dr. Kutner is also the founder and first Medical Director of the sleep laboratory at Baptist Hospital of Miami. He is presently the chairman and founding member of Physicians Health Alliance, a value-based management services organization affiliated with United Healthcare. Dr. Kutner is also a co-founder and Board member of two Florida property casualty companies, America Traditions, and Modern USA Property Casualty. Other business interests have included a chain of Costa Rican pharmacies, Farmacia Express, which introduced the country to a toll-free telephone number for the order and delivery of prescriptions to the home, and Colombian sleep labs. Dr. Kutner attended CCNY School of Biomedical Education and graduated from SUNY Stony Brook with a Medical Doctor degree. He completed a residency in Internal Medicine at Northwestern University, and a fellowship at Johns Hopkins University School of Medicine in Pulmonary, Critical Care, and Sleep Medicine, as well as a fellowship at Johns Hopkins School of Hygiene and Public Health in Environmental Health Sciences. He has been board certified in Critical Care Medicine, Internal Medicine, Pulmonary Medicine and Sleep Medicine. He is affiliated with insurance companies, physicians’ groups, ACOs, hospital groups, and private equity planning the future of healthcare in Florida. The Board believes that Dr. Kutner’s experience as a founder, executive and director of a variety of private companies brings valuable experience to the Board in matters such as organizational structure, corporate strategy, operational performance measurement and improvement and governance.

 

4 
 

 

Scott Howell, MD – Director.

 

Dr. Scott Howell, age 57, has served as a Company director since 2017. Dr. Howell is currently a practicing physician for more than 25 years. Dr. Howell is board certified in Family Practice, Preventative Medicine and Public Health and Addiction Medicine. Presently, Dr. Howell advises healthcare organizations with regulatory, product development, reimbursement and financial modeling for multiple healthcare organizations. Dr. Howell is the medical director at the AIDS Healthcare Foundation Chronic Care Special Needs Plan (C-SNP) since 2019 to the present. In 2018, Dr. Howell launched 11.2 Healthcare, Inc. a private healthcare finance consulting organization concentrating on managed care, medical devices and financing of developmental companies. From 2017 to 2018, Dr. Howell was the Chief Medical Officer at Advantmed, a healthcare analytics and delivery organization. From 2015 to 2017, Dr. Howell was an executive medical director for Heritage Development Organization, for which he participated in national expansion through joint ventures, mergers & acquisitions and by identifying enterprise-wide clinical solutions. From 2008 to 2015, Dr. Howell was the National Senior Medical Director and Chief Medical Officer for Network and Population Health at Optum Insight, responsible for risk adjustment, quality performance, networks, predictive modeling and clinical consulting, including as the Regional Chief Medical Officer (RCMO) for the Northeast Region of Americhoice, Inc. focusing on the Medicaid and Dual SNP populations. From 2000 to 2008, Dr. Howell was the Medical Director for Managed Care at the AIDS Healthcare Foundation, the first HIV SNP in the nation, and was responsible for international consulting in Russia, Ukraine, Guatemala, Honduras, and Haiti. During this period, Dr. Howell was the lead scientific advisor to Management Sciences for Health, the prime contractor for PEPFAR in Haiti. Dr. Howell has a Master’s in Economics from the University of Miami, a Master’s in Public Health and Tropical Medicine, (MPH&TM) from Tulane University, and a Master’s in Business Administration (MBA) from California State University Fresno. Dr. Howell is currently retired from the Air Force after 25 years of service with the rank of Colonel. His last assignment was with the Office of Secretary of Defense (OSD) at the Department of Defense Inspector General (DoDIG) in Special Plans and Operations (SPO). The Board believes that Dr. Howell extensive experience in management and consulting brings to the Board and management perspective on dealing with governmental regulations and growth of its business.

 

INFORMATION ABOUT THE DIRECTORS CONTINUING IN OFFICE UNTIL THE 2024 ANNUAL MEETING

Brian Krogol – Director, Chief Financial Officer.

 

Brian Krogol, age 34, has been our Chief Financial Officer since June 2021. Mr. Krogol joined Standard Premium Finance Holdings, Inc. as Vice President of Accounting in October 2019. Brian Krogol graduated from the Fisher School of Accounting at the University of Florida with a Master of Accounting (MAcc) in 2011. From 2011-2013, he worked as an auditor with Grant Thornton, an international organization of independent assurance, tax, and advisory firms, gaining audit experience with companies in the health care, manufacturing, distribution, hospitality, restaurant, and financial industries, as well as, experience on 10-Q, 10-K, SOX 404, benefit plan, and IPO engagements for SEC clients, as well as quarter- and year-end engagements for private clients reporting under US GAAP. Mr. Krogol gained recognition for earning the prestigious Elijah Watt Sells award in 2012 for his performance on the Certified Public Accountant examination. Of more than 92,000 candidates who sat for the examination in 2012, only thirty-nine candidates met the criteria for this award. On the tailwind of this award, from 2013-2019, Mr. Krogol operated a private tutoring business, primarily preparing students for the CPA exam, as well as college level accounting, finance, economics, and mathematics courses. During this period, from 2015 to 2018, Mr. Krogol joined Clutch Prep as Lead Business Instructor, designing and maintaining online curriculum, including recording instructional videos for undergraduate level accounting, finance, and economic courses. The board believes that Mr. Krogol provides essential insight into the Company’s financial affairs.

 

James Wall – Director.

 

James Wall, age 74, has served as a director of Holdings since 2017 and has been a director on the Board of the Company's Standard Premium Finance Management Corporation subsidiary since 2004. Mr. Wall was instrumental in the Board of Directors agreeing to change Standard Premium Finance Management Corporation from a sub chapter "S" corporation to a "C" corporation so that a holding company could be created. In 2005, Mr. Wall retired from a career as a commercial airline pilot where he worked for American Airlines from 1989 until 2005. Notably, he gained industry experience as a commercial loan credit analyst during a furlough period with Eastern Airlines, where he was a commercial pilot for Eastern Airlines from 1973 until its bankruptcy in 1989, also working two years for Atlantic Bank. Mr. Wall joined the United States Navy as a pilot in 1973 and remaining in the Naval Reserve until 1988 when he retired at the rank of Captain. Mr. Wall earned a bachelor’s degree from Wake Forest University, and an MBA from the University of North Florida. The Board believes that Mr. Wall’s long-term service as a director of the Company’s subsidiary provides essential insight into the Company’s operations as well as institutional memory that benefits the entire Board as well as management.

 

5 
 

 

INFORMATION ABOUT THE DIRECTORS CONTINUING IN OFFICE UNTIL THE 2025 ANNUAL MEETING

 

John C. Leavitt, DBA – Director.

 

John C. Leavitt, age 60, has served as a Company director since 2017. Mr. Leavitt is a Certified Project Management Professional (“PMP”) as well as Program Management (“PgMP”) with more than 25 years of management, technical and engineering experience in Government DOD, DOS, and NASA IT and Communications systems such as SATCOM, Commercial RF Systems and telecommunications. Mr. Leavitt is currently employed with the National Aeronautics and Space Administration (NASA), since July 2016, and is responsible for ensuring desktop computer and communication systems are meeting mission requirements and configured for launch support under the Office of Chief Information Office within NASA. Previous assignments include IT Architect for the Commercial Crew Program helping to launch American Astronauts to the International Space Station (ISS). He has managed multiple complex high-profile projects using PMI-methods and NASA Best practices. As a consultant Mr. Leavitt has assisted in writing proposals and white papers for customers on large Government and commercial companies such as American Access Technologies, ASRC Aerospace, MASTEC, SAIC and Yang Engineering. Mr. Leavitt has been a speaker for project management conferences across the US. Mr. Leavitt graduated magna cum laude with his Bachelors of Science in Engineering Technologies (BS-EET) from the University of Central Florida, earning his MBA from Keller Graduate School of Management, and Doctorate in Business Administration (DBA) specializing in Information Systems Management at Walden University. The Board believes that Mr. Leavitt’s experience in project management and government contracting assists the Board and management in strategic planning and managing for growth.

 

Christopher Perrucci, Esq, - Director.

 

Christopher Perrucci, age 60, has served as a Company director since 2017. Mr. Perrucci has been a licensed attorney in Ohio since 1985 and has over 33 years of legal and business experience focused on contracts, information systems and services, and business management. Currently, Mr. Perrucci engages in the following principal occupations and organizations: C R Perrucci Co., LPA, Law Firm as a Managing Attorney since 2015; SOI Online, LLC, Online Information Company as the President/CEO since 2015 and Max Technologies, LLC, Probation/Parole Monitoring as the President/CEO since 2015. In 2002, Mr. Perrucci founded SOI Online, which provides a retail online service for criminal background checks, OnlineCriminalChecks.com, which he still operates today as the President. Prior to these engagements, Mr. Perrucci had several notable business successes. In 2012, he founded and operated Max Technologies, a unique technology-based monitoring system to assist Ohio Courts and Probation Departments, Ohio parolee supervision and warrant tracking. Mr. Perrucci spent four years with Database Technologies from June 1996 to December 1999, where he served as Vice President and Director of Business Development, responsible for data acquisition, product and database development, and new business development. He assisted the company with its transition to DBT Online and its IPO listing on the NYSE. Prior to that, Mr. Perrucci spent 10 years in product and systems development, licensing, and data acquisition for Lexis-Nexis, the largest legal information company in the world. Mr. Perrucci also served as President of Intellicorp for four years from January 2000 to April 2004, growing the business from $200k and two employees into $4m and 25 employees. He recently completed the acquisition of North Carolina Information Data, Inc., an online provider of retail and wholesale information services to lawyers, bondsman, and general businesses. Mr. Perrucci was born and raised in Indiana and earned a Bachelor of Science degree in Legal Administration from Ball State University in 1982 and a law degree from the University of Dayton, School of Law in 1985. The Board believes that Mr. Perrucci’s experience in information systems aids the Board and management in overseeing the Company’s information technology functions.

 

Carl C. Hoechner – Director.

 

Carl C. Hoechner, age 63, has served as a Director for Holdings since its inception in 2017. Mr. Hoechner invested capital in Standard Premium Finance Management Corporation in 2011 and has served as a member of its Board of Directors since 2011. As such, Mr. Hoechner has assisted in to raising several million dollars in Subordinated Notes from many investors. Mr. Hoechner is also an entrepreneur in tourism and real estate. Since 2000 and presently, he has owned and operated the C.L. Hoechner Overseas Tours, Inc. with most of its operations remaining in Europe. He also actively continues his career as a real estate developer, remodeling and selling properties to multinational and foreign investors. Mr. Hoechner was born in the US (Florida), but raised in Oberammergau, DE, Carl Hoechner studied and received the equivalent of a BS in Economics and Tourism from Industry and Trade Chamber of Munich, located in Munich Germany. As a multinational entrepreneur, Mr. Hoechner moved back to the US in 2001, and made his primary residence in Miami, Florida. The Board believes that Mr. Hoechner’s experience as lead investor in the Company’s subordinated notes provides the Board and management with insight into the interests and concerns of the Company’s investors.

 

6 
 

 

Director Independence

 

The Board of Directors discussed and reviewed whether each nominee is independent within the Company’s corporate governance guidelines which are consistent with the director independence standards established by The Nasdaq Stock Market LLC. In determining independence, the Board reviews and seeks to determine whether directors have any material relationship with the Company, direct or indirect, which would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. The Board reviews business, professional, charitable and familial relationships of the independent directors in determining independence. The Board has determined that Carl Hoechner, Mark Kutner, MD, James Wall, Chris Perrucci, John Leavitt and Scott Howell, MD, are independent.

 

Information about the Nominating Process

 

The Board of Directors has established a Nominating Committee which undertakes the activities of identifying, evaluating and selecting nominees to serve as directors.

 

Nomination of Director Candidates by Stockholders

 

The policy of the Nominating Committee is to consider nominations of candidates for membership on the Board of Directors that are submitted by stockholders. Any such recommendations should include the nominee’s name and qualifications for Board membership and a consent signed by such candidate to serve as a director if elected and should be directed to Margaret Ruiz, Corporate Secretary, Standard Premium Finance Holdings, Inc., 13590 SW 134th Avenue, Suite 214, Miami, FL 33186.

 

Stockholders may nominate candidates for election as directors at the Annual Meeting by attending the meeting and offering the candidates into nomination at the time of the election of directors.

 

For a stockholder’s nominees to be included in the Company’s Proxy Statement for next year’s annual meeting the stockholder must give timely notice to the Company by the date set forth below under “Stockholder Proposals for Next Annual Meeting.”

 

Director Qualifications

 

The Board of Directors has not established any minimum qualifications for nomination as a director of the Company but has identified the following qualities and skills necessary for our directors to possess:

 

·Integrity
·Commitment to enhancing stockholder value
·Ability to objectively analyze complex business problems and develop creative solutions
·Pertinent expertise, experience and achievement in education, career and community
·Familiarity with issues affecting the Company’s business
·Availability to fulfill time commitment
·Ability to work well with other directors

 

Identifying and Evaluating Nominees for Directors

 

Candidates for director may come from a number of sources including, among others, recommendations from current directors, recommendations from management, third-party search organizations, and stockholders. Director candidates are evaluated to determine whether they have the qualities and skills set forth above. Such evaluation may be by personal interview, background investigation and other appropriate means. The Board of Directors does not have a formal policy with regard to the consideration of diversity in identifying director nominees. However, in identifying nominees for director, the Board does seek to have directors with a diversity of business experience and skills which allow for the expression of diverse viewpoints.

 

Director Attendance at the 2022 Annual Meeting

 

The Company expects all of its directors to attend the annual meeting of stockholders. Five of our directors attended the Annual Meeting held in 2022.

 

7 
 

 

Stockholder Communications with the Board

 

Stockholders may communicate with the Board in writing by addressing mail to “Board of Directors” c/o Margaret Ruiz, Corporate Secretary, Standard Premium Finance Holdings, Inc., 13590 SW 134th Avenue, Suite 214, Miami, FL 33186. Any such communication will be distributed to each of the Company’s directors. A communication addressed to any individual director at the same address will be distributed only to that director.

 

Board Leadership Structure

 

The objective of the Board’s leadership structure is to provide effective and independent oversight of management on behalf of the stockholders. The Board’s three standing committees are described below.

 

The Board believes its leadership structure provides effective and independent Board oversight of management.

 

Board Committees

 

The Board of Directors of the Company has a standing Audit Committee, Compensation Committee and Nominating Committee.

 

Audit Committee

 

The Board adopted its current Audit Committee Charter on April 25, 2022. The principal functions of the Audit Committee are to review and monitor the Company’s financial reporting and the internal and external audits. The committee’s functions include, among other things: (i) to select and replace the Company’s independent registered public accounting firm; (ii) to review and approve in advance the scope and the fees of our annual audit and the scope and fees of non-audit services of the independent registered public accounting firm; (iii) to receive and consider a report from the independent registered public accounting firm concerning their conduct of the audit, including any comments or recommendations they might want to make in that connection; and (iv) to review compliance with and the adequacy of our major accounting and financial reporting policies and controls. The members of the Audit Committee are currently Scott Howell, MD, Mark Kutner, MD, and John Leavitt, DBA. The Audit Committee met four times during the fiscal year ended December 31, 2022. The Board has determined that Messrs. Howell, Kutner and Leavitt are “independent” as defined in the rules of the The Nasdaq Stock Market LLC and that Mr. Howell qualifies as an “audit committee financial expert” as defined in the regulations of the Securities and Exchange Commission. A copy of the Audit Committee charter is available at https://standardpremiuminvestors.com.

 

Compensation Committee

 

The Board of Directors established the Compensation Committee as a standing committee on December 21, 2020. The primary functions of the Compensation Committee are to review and approve the compensation of the Chief Executive Officer and the other executive officers of the Company, to recommend the compensation of the directors, to review and approve the terms of any employment agreements with executive officers and to produce an annual report for inclusion in the Company’s proxy statement. The Compensation Committee also administers and interprets the Company’s equity compensation and employee benefit plans and grants all awards under the employees stock incentive plan. The members of the Compensation Committee are currently Scott Howell, MD and Christian Hoechner. The Board of Directors determined that Messrs. Howell and Hoechner are considered independent as defined in the rules of the The Nasdaq Stock Market LLC. A copy of the Compensation Committee charter is available at https://standardpremiuminvestors.com.

 

Nominating Committee

 

The Board of Directors established the Nominating Committee as a standing committee on December 21, 2020. The principal purposes of the Nominating Committee are to identify individuals qualified to become Board members, consistent with criteria approved by the Board, and to select the director nominees of the Board to stand for election at each annual meeting of stockholders.

 

Board’s Role in Risk Management

 

The Board of Directors, through the Audit Committee, works with management to identify and provides oversight of the implementation and operation of the Company’s risk management processes.

 

8 
 

 

Code of Ethics

 

The Company has adopted a code of business conduct and ethics for its directors, officers and employees. A copy of the code of business conduct and ethics is available at https://standardpremiuminvestors.com

 

Attendance at Meetings

 

During the fiscal year ended December 31, 2022, the Board of Directors held six meetings, all of which were telephonic. No member of the Board of Directors attended fewer than 75% of the meetings of the Board held in 2022.

 

Delinquent Section 16(a) Reports

 

Section 16(a) of the Exchange Act requires our officers and directors and persons who own more than 10% of our common stock to file reports of ownership and changes in ownership of our common stock with the SEC. Based on our review of the copies of such reports, we believe that all such reports required by Section 16(a) of the Exchange Act were in compliance with such filing requirements during the fiscal year ended December 31, 2022 other that the following: (1) Brian Krogol filed a late Form 4 and (2) Carl Hoechner filed two late Form 4s.

2022 Director Compensation

 

The Company did not pay any directors compensation for their service on the Board of Directors during the year ended December 31, 2022. Messrs. Koppelmann and Krogol received compensation for services as executive officers and no compensation for Board service.

 

Certain Relationships and Related Transactions

 

All related party transactions are required to be reviewed and approved by an independent body of the Board of Directors composed solely of independent directors as defined in The Nasdaq Stock Exchange LLC governance rules.

 

Reference is hereby made to Notes 8, 11, 13 and 15 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission on March 17, 2023 for further information concerning related party transactions.

 

 

9 
 

 

PROPOSAL NO. 2

TO RATIFY THE SELECTION OF THE COMPANY’S

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2023

 

The Board of Directors is asking the stockholders to ratify the Audit Committee’s selection of Assurance Dimensions, LLC, as the Company’s independent registered public accounting firm for 2023. In the event the stockholders fail to ratify the selection, the Audit Committee will reconsider its selection.

 

Representatives of Assurance Dimensions, LLC, are expected to be present at the Annual Meeting in person or by conference telephone and will have the opportunity to make a statement if they desire to do so. It is also expected that they will be available to respond to appropriate questions. Assurance Dimensions, LLC, has been our independent registered public accounting firm since the fiscal year ended December 31, 2022.

 

Fees billed for services provided by our independent registered public accounting firm for 2022 and 2021 were as follows:

 

   Year Ended December 31, 
Types of Fees  2022   2021 
Audit Fees (1)  $58,500   $61,500 
Audit-Related Fees (2)   —    — 
Tax Fees (3)   2,500    2,500 
Other Fees (4)   —    — 
Total Fees  $61,000   $64,000 

———————
(1)Audit fees consist of fees billed for professional services rendered for the audit of our annual consolidated financial statements and review of our interim condensed consolidated financial statements included in our quarterly reports, professional services rendered in connection with our filing of various registration statements and other services that are normally provided by Assurance Dimensions, LLC, and Liggett & Webb, P.A. in connection with statutory and regulatory filings or engagements.
(2)Audit-related fees consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements and are not reported as audit fees.
(3)Tax fees consist of fees billed for professional services rendered for tax compliance, tax advice and tax planning (domestic and international).
(4)All other fees consist of fees billed for products and services other than the services described in notes (1), (2) and (3) above.

 

Change in Registered Public Accountant

 

On October 11, 2022, the Company, received the resignation of Liggett & Webb P.A. (“L&W”) as our independent registered public accountant, effective immediately. The resignation of L&W was approved by the Audit Committee of the Board of Directors.

 

The reports of L&W on the Company’s financial statements for the years ended December 31, 2021 and 2020 did not contain an adverse opinion or disclaimer of opinion, and such reports were not qualified or modified as to uncertainty, audit scope, or accounting principle.

 

During the years ended December 31, 2021 and 2020 and the subsequent interim period through October 11, 2022, the Company has not had any disagreements with L&W on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to L&W’s satisfaction, would have caused them to make reference thereto in their reports on the Company’s consolidated financial statements for such periods.

 

During the years ended December 31, 2021 and 2020 and the subsequent interim period through October 11, 2022, there were no reportable events, as defined in Item 304(a)(1)(v) of Regulation S-K.

 

The Company provided L&W with a copy of the disclosures it is making in this Current Report on Form 8-K (the “Report”) prior to the time the Report was filed with the Securities and Exchange Commission (the “SEC”). The Company requested that L&W furnish a letter addressed to the SEC stating whether or not it agrees with the statements made herein. A copy of L&W’s letter, dated October 12, 2022, is attached as Exhibit 16.1 to the Company’s Current Report on Form 8-K filed on October 12, 2022.

 

10 
 

 

On January 23, 2023, the Audit Committee of the Board of Directors of Standard Premium Finance Holdings, Inc. (the “Company”) engaged Assurance Dimensions, Inc. to serve as the Company’s independent registered public accounting firm.

 

During the two most recent fiscal years ended December 31, 2021 and 2020 and through the date the Company selected Assurance Dimensions, Inc. as its independent registered public accounting firm, neither the Company nor anyone on behalf of the Company consulted Assurance Dimensions, Inc. regarding any accounting or auditing issues involving the Company, including (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, or (ii) any matter that was the subject of a “disagreement” (as defined in Item 304(a)(1)(iv) of Regulation S-K of the Securities Exchange Act of 1934, as amended, and the related instructions to Item 304 of Regulation S-K) or a “reportable event” (as defined in Item 304(a)(1)(v) of Regulation S-K).

 

AUDIT COMMITTEE REPORT

 

The Audit Committee has reviewed and discussed with the Company’s management and Assurance Dimensions, LLC, the audited consolidated financial statements of the Company contained in the Company’s Annual Report on Form 10-K for the Company’s 2022 fiscal year. The Audit Committee has also discussed with Assurance Dimensions, LLC, the matters required to be discussed pursuant to Auditing Standard No. 1301 issued by the Public Company Accounting Oversight Board (“PCAOB”).

 

The Audit Committee has received and reviewed the written disclosures and the letter from Assurance Dimensions, LLC required by the applicable requirements of the PCAOB regarding the independent accountant’s communications with the audit committee concerning independence and has discussed with Assurance Dimensions, LLC, its independence from the Company.

 

The Audit Committee has considered whether the provision of services other than audit services is compatible with maintaining auditor independence.

 

Based on the review and discussions referred to above, the Audit Committee recommended to the Board of Directors that the audited consolidated financial statements be included in the Company’s Annual Report on Form 10-K for its 2022 fiscal year for filing with the SEC.

 

  Respectfully submitted,
  Scott Howell, MD
  Mark Kutner, MD
  John Leavitt, DBA
   

 

11 
 

 

Audit Committee’s Pre-Approval Policies

 

The Audit Committee’s policy is to pre-approve all audit services and all permitted non-audit services (including the fees and terms thereof) to be provided by the Company’s independent registered public accounting firm; provided, however, pre-approval requirements for non-audit services are not required if all such services (1) do not aggregate to more than five percent of total revenues paid by the Company to its independent registered public accounting firm in the fiscal year when services are provided; (2) were not recognized as non-audit services at the time of the engagement; and (3) are promptly brought to the attention of the Audit Committee and approved prior to the completion of the audit by the Audit Committee.

 

The Audit Committee pre-approved all of the fees described above.

 

The Audit Committee has considered whether the provision of the above services other than audit services is compatible with maintaining auditor independence.

 

Vote Required

 

The affirmative vote of a majority of the shares of Common Stock present at the Annual Meeting and voting on the proposal is required to ratify the selection of the Company’s independent registered public accounting firm for 2022. Abstentions and broker non-votes have no effect on the vote on the proposal.

 

THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE “FOR” PROPOSAL NO. 2, TO RATIFY THE SELECTION OF THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2023.

 

 

12 
 

 

PROPOSAL NO. 3

 

TO APPROVE THE ISSUANCE OF UP TO 1,400,000 COMMON STOCK PURCHASE WARRANTS TO COMPANY DIRECTORS, OFFICERS AND CONSULTANTS AND ISSUANCE OF UP TO 1,400,000 SHARES OF COMMON STOCK UPON THE EXERCISE OF SUCH WARRANTS.

 

In March 2019, the Board of Directors approved a compensation plan for Company directors, officers and consultants consisting of 1,000,000 common stock purchase warrants. In June 2021, the Board authorized the issuance of an additional 400,000 warrants for issue under the plan. The Company currently has six directors who received 240,000 warrants as compensation for services, two officers who received 155,000 warrants as compensation for services and two consultants who received 475,000 warrants as compensation for services. There are 365,000 authorized warrants available for issuance as of April 25, 2023. There are no current agreements to issue additional warrants.

 

Participation in the compensation plan is determined by grant of warrants to designated participants by the Board of Directors. The Board authorized the Company’s Chief Executive Officer to designate up to 225,000 warrants for personnel retention and hiring, 60,000 of which have been issued.

 

The common stock purchase warrants issued and to be issued under the plan have a term of five (5) years from date of issuance. There are currently 635,000 issued and outstanding warrants having an exercise price per share of common stock of $4.00 and 400,000 issued and outstanding warrants have an exercise price per share of common stock of $12.00 per share. The warrants may be exercised for cash or by cashless exercise. Cashless exercise would only be available if the market price of the Company’s common stock is greater than the exercise price of the warrants at the time of exercise and would result in the warrant-holder receiving less shares of common stock upon cashless exercise of warrants.

 

As of April 25, 2023 the market value of the common stock underlying the 635,000 outstanding $4.00 warrants is $2.02 per warrant, based on the difference between the $4.00 exercise price of the warrants and closing bid quotation for our common stock on the OTCQX on April 25, 2023. Quotes on the OTCQX represent inter-dealer prices which do not include retail mark-ups, mark-downs, or commissions and may not necessarily represent actual transactions. As of April 25, 2023 the market value of the common stock underlying the 400,000 outstanding $12.00 warrants is $0 per warrant due to the $6.02 closing bid quotation for our common stock being less than the $12.00 exercise price of the warrants.

 

Securities Law Compliance

 

In the event that the warrants and the shares common stock to be acquired upon exercise of the warrants are not covered by a then current registration statement under the Securities Act of 1933 (the “Securities Act”), and is not otherwise exempt, such warrants and shares will be restricted against transfer to the extent required to comply with the Securities Act and the warrants or underlying shares of common stock will contain a restriction on transfer which prevents distribution of the warrants and the underlying shares without compliance with the Securities Act.

 

The Board of Directors is requesting that the stockholders approve the issuance of the 1,400,000 warrants and the 1,400,000 shares of common stock underlying the warrants as required by the By-laws of the Company.

 

Vote Required

 

The affirmative vote of a majority of the shares of common stock present at the Annual Meeting and voting on the proposal is required to approve the issuance of up to 1,400,000 common stock purchase warrants to Company directors, officers and consultants and issuance of up to 1,400,000 shares of common stock upon the exercise of such warrants.

Abstentions and broker non-votes have no effect on the vote on the proposal.

 

THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE “FOR” THE APPROVAL OF THE ISSUANCE OF UP TO 1,400,000 COMMON STOCK PURCHASE WARRANTS TO COMPANY DIRECTORS, OFFICERS AND CONSULTANTS AND ISSUANCE OF UP TO 1,400,000 SHARES OF COMMON STOCK UPON THE EXERCISE OF SUCH WARRANTS.

 

 

 

13 
 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

The following table sets forth certain information regarding the beneficial ownership of our common stock and Series A Convertible Preferred Stock as of March 17, 2023 by (i) each stockholder who is known by the Company to own beneficially more than five percent of any class of the Company’s voting securities, (ii) each current director of the Company, (iii) each of the Company’s current executive officers, and (iv) all executive officers and directors of the Company as a group. Except as indicated in the footnotes to the table, the listed stockholders hold sole voting and investment power over their respective shares. The information as to each person or entity is based upon the Company’s records and information provided to the Company.

 

   Common Stock   Series A Convertible Preferred Stock 
Name  Number of Shares (a)   Percent of Class (a)   Number of Shares   Percent of Class 
William Koppelmann   903,655(b)   21.9%          
Brian Krogol   138,800(c)   3.4%   2,000    1.2%
Carl C. Hoechner   196,076(d)   4.8%          
Mark Kutner, MD   241,500(e)   5.9%   50,000    30.1%
James Wall   103,256(f)   2.5%          
Chris Perrucci   91,500(g)   2.2%          
John Leavitt   91,500(h)   2.2%          
Scott Howell, MD   91,500(i)   2.2%          
Victor Galliano   43,259(j)   1.0%          
Robert Mattucci   39,303(k)   1.0%          
Margaret Ruiz   27,478(l)   <1%           
                     
All Officers and Directors as a Group (11 persons)   1,967,827    47.7%          
                     
Shareholders with greater than 5%:                    
MaryLea Boatwright   286,748    6.9%          

———————
(a)A party is deemed to be a beneficial owner of shares that can be acquired by such person within 60 days from March 17, 2023, upon their exercise of options and warrants. Each beneficial owner’s percentage of ownership is determined by assuming that options and warrants that are held by such party (but not those held by any other party) and are exercisable or convertible by such party within 60 days from that date have been so exercised or converted.
(b)Consists of (i) 803,655 shares owned by Mr. Koppelmann directly, (ii) 25,000 shares issuable upon exercise of Class W4 five-year warrants at an exercise price of $4.00 per share, and (iii) 75,000 shares issuable upon exercise of Class W12 five-year warrants at an exercise price of $12.00 per share.
(c)Consists of (i) 100 shares owned by Mr. Krogol directly, (ii) 83,700 shares issuable upon exercise by Mr. Krogol of ten-year stock options at an exercise price of $0.80 per share, (ii) 5,000 shares issuable upon exercise of Class W4 five-year warrants at an exercise price of $4.00 per share and (iii) 50,000 shares issuable upon exercise of Class W12 five-year warrants at an exercise price of $12.00 per share.
(d)Consists of (i) 171,076 shares owned by Mr. Hoechner directly and (ii) 25,000 shares issuable upon exercise of Class W12 five-year warrants at an exercise price of $12.00 per share.
(e)Consists of (i) 126,500 shares owned by Dr. Kutner directly, (ii) 15,000 shares issuable upon exercise of Class W4 five-year warrants at an exercise price of $4.00 per share, (iii) 50,000 shares issuable upon exercise of Class W12 five-year warrants at an exercise price of $12.00 per share, and (iv) 50,000 shares issuable upon exercise of Class W4A five-year warrants at an exercise price of $4.00 per share.
(f)Consists of (i) 78,256 shares owned by Mr. Wall directly and (ii) 25,000 shares issuable upon exercise of Class W12 five-year warrants at an exercise price of $12.00 per share.
(g)Consists of (i) 66,500 shares owned by Mr. Perrucci directly and (ii) 25,000 shares issuable upon exercise of Class W12 five-year warrants at an exercise price of $12.00 per share.
(h)Consists of (i) 66,500 shares owned by Mr. Leavitt directly and (ii) 25,000 shares issuable upon exercise of Class W12 five-year warrants at an exercise price of $12.00 per share.
(i)Consists of (i) 66,500 shares owned by Mr. Howell directly and (ii) 25,000 shares issuable upon exercise of Class W12 five-year warrants at an exercise price of $12.00 per share.
(j)Consists of (i) 15,359 shares owned by Mr. Galliano directly and (ii) 27,900 shares issuable upon exercise of ten-year stock options at an exercise price of $0.80 per share.
(k)Consists of (i) 11,403 shares owned by Mr. Mattucci directly and (ii) 27,900 shares issuable upon exercise of ten-year stock options at an exercise price of $0.80 per share.
(l)Consists of (i) 17,478 shares owned by Ms. Ruiz directly and (ii) 10,000 shares issuable upon exercise of ten-year stock options at an exercise price of $0.80 per share.

 

Address of William J. Koppelmann, Carl Christian Hoechner, Mark Kutner, James Wall, Chris Perrucci, John Leavitt, Scott Howell, Victor Galliano, Robert Mattucci, Margaret Ruiz, and Brian Krogol is 13590 SW 134th Avenue, Suite 214, Miami, FL 33186. Address of MaryLea Boatwright is 3889 Admiral Drive, Chamblee, GA 30341.

 

 

14 
 

 

EXECUTIVE OFFICERS

Our current executive officers are:

 

Name   Principal Position
William Koppelmann   Chief Executive Officer, President
Brian Krogol   Chief Financial Officer
Robert Mattucci   Vice President of Sales
Victor Galliano   Vice President of Marketing 
Margaret Ruiz   Operations Manager and Secretary

Information about William Koppelmann and Brian Krogol is contained in “Election of Directors” above.

 

Robert Mattucci – Vice President of Sales

 

Robert Mattucci, age 57, has been our Vice President of Sales since September 2019 overseeing sales throughout the nation. Originally hired as a marketing representative for the west coast of Florida in 2006, Mr. Mattucci was directly responsible for achieving a 300% growth in sales over a 3-year period in the region. His primary duties involve the recruitment and training of all new sales personnel. After being promoted to National Sales Manager in 2009, Mr. Mattucci developed sales operations in Dallas, Atlanta and Charlotte.

 

Victor Galliano – Vice President of Marketing

 

Victor Galliano, age 58, has been the Vice President of Marketing for Holdings since September 2019 and works for SPFMC since 2008. Victor Galliano has over 25 years of sales experience working in the insurance premium finance industry. In January 2008, Mr. Galliano became regional sales manager for Standard Premium Finance and has been recognized as the lead sales representative every year thereafter. With his vision and efforts, he was able to expand sales statewide. In 2012, he was promoted to VP of Sales for Florida and was responsible for developing and implementing a statewide sales strategy that led to yearly organic growth. During this time, he also helped launch various national sales campaigns and trained junior sales staff members. In addition, Mr. Galliano earned an MBA, with a specialization in accounting, from St. Thomas University in 2001.

 

Margaret Ruiz – Operations Manager and Secretary.

 

Margaret Ruiz, age 60, has been our Operations Manager and Secretary since 2017. Since August 2000, she has served as Operations Manager of Standard Premium Finance Management Corporation. Prior to joining Standard Premium Finance Management Corporation in August 2000, Margaret Ruiz gained nearly 20 years of commercial banking experience with SunTrust Bank from 1980 to 1997 and Office Manager at Professional Therapeutic Alternatives from 1997 to 2000. Her early career in Human Resources was spent in recruiting and employment matters. She was responsible for the nonexempt staffing for SunTrust’s 1500 employees. Ruiz is proficient in computer operations, having worked for three years in the bank’s data center, acting as liaison for branch personnel in all aspects of technical issues related to retail banking. Ms. Ruiz is an integral part of the Company’s management, in charge of the day to day operations and the supervision of 12 staff members. She oversees the customer service provided to more than 600 agents and agencies throughout the Southeast United States and Texas. Ms. Ruiz is involved in most aspects of audit requirements imposed by the Company’s lender and governing entities, ensuring compliance by administering strict internal control procedures. Most notable of Ms. Ruiz’s recent accomplishments is the successful overhaul of the operating system, converting over 20,000 customer records and implementing new procedures. Margaret Ruiz is William Koppelmann’s sister.

 

 

15 
 

EXECUTIVE COMPENSATION

 

Overview and Objectives

 

We believe our success depends on the continued contributions of our named executive officers. We have established our executive compensation program to attract, motivate, and retain our key employees in order to enable us to maximize our profitability and value over the long term. Our policies are also intended to support the achievement of our strategic objectives by aligning the interests of our executive officers with those of our shareholders through equity-based compensation. We expect that our compensation program will continue to be focused on building long-term shareholder value by attracting, motivating and retaining talented, experienced executives and other key employees. Currently, our Compensation Committee oversees the compensation programs for our executive officers.

 

Elements of Compensation

 

Historically, we have compensated our named executive officers with annual base salaries, annual cash bonuses, and employee benefits. Additionally, our named executive officers may be awarded equity incentives in the form of stock purchase warrants and stock purchase options. We expect that these elements will continue to constitute the primary elements of our compensation program, although the relative proportions of each element, and the specific plan and award designs, will likely evolve as we become a more established public company.

 

Employment, Severance or Change in Control Agreements

 

We are not party to any agreements with our executive officers that provide benefits upon termination of employment. Currently the executive officers are employed at will with no present arrangements or pledges of the Company’s securities which may result in a change of control of the Company.

 

Base Salary

 

Base salary is the fixed annual compensation we pay to each of our named executive officers for carrying out their specific job responsibilities. Base salaries are a major component of the total annual cash compensation paid to our named executive officers. Base salaries are determined after taking into account many factors, including (a) the responsibilities of the officer, the level of experience and expertise required for the position and the strategic impact of the position; (b) the need to recognize each officer’s unique value and demonstrated individual contribution, as well as future contributions; (c) the performance of the company and each officer; and (d) salaries paid for comparable positions in similarly-situated companies.

 

For the amounts of base salary that our named executive officers received in 2022 and 2021, see “Executive Compensation-Summary Compensation Table.”

 

Our Compensation Committee reviews the base salaries for each named executive officer periodically as well as at the time of any promotion or significant change in job responsibilities and, in connection with each review, considers individual and company performance over the course of the relevant time period. The Board may make adjustments to base salaries for named executive officers upon consideration of any factors that it deems relevant, including but not limited to: (a) any increase or decrease in the named executive officer’s responsibilities, (b) the named executive officer’s job performance, and (c) the level of compensation paid to senior executives of other companies with whom we compete for executive talent, as estimated based on publicly available information and the experience of our directors.

 

Annual Cash Bonuses

 

Annual cash bonuses are determined in the discretion of our Board. At this time there is defined bonus plan for the CEO and CFO. For the fiscal years ended December 31, 2022 and 2021, all of our named executive officers were awarded cash bonuses as set forth in “Executive Compensation-Summary Compensation Table.”

 

Other Benefits

 

We offer participation in broad-based retirement, health and welfare plans to all of our employees.

 

Risk Considerations

 

The Compensation Committee considers whether the Company’s compensation policies and practices for both executives and other employees encourage unnecessary or excessive risk taking.

 

16 
 

 

Base salaries are not believed to encourage excessive risk taking. The Company’s bonus compensation and equity compensation practices do not focus on achievement of annual Company and/or individual performance goals and are not believed to encourage unnecessary or excess risk taking.

 

 

 

Pension Benefits

 

We have not maintained and do not currently maintain a defined benefit pension plan or a supplemental executive retirement plan. Instead, our employees, including our named executive officers, may participate in a retirement plan intended to provide benefits under section 401(k) of the Code (the “401(k) Plan”) pursuant to which employees are allowed to contribute a portion of their base compensation to a tax-qualified retirement account in a defined safe harbor 401(k) Plan, subject to limitations.

 

Non-Qualified Defined Contribution and Other Non-Qualified Deferred Compensation Plans

 

We have not had and do not currently have any defined contribution or other plan that provides for the deferral of compensation on a basis that is not tax-qualified.

 

2019 Equity Incentive Plan

 

On December 17, 2019, the Board of Directors of the Company adopted the 2019 Equity Incentive Plan (the “2019 Plan”). The 2019 Plan provides for the award of Incentive or Non-Statutory Stock Options, Stock Purchase Rights, Stock Awards and Unrestricted Stock. Awards may be granted under the 2019 Plan to employees, directors and consultants of the Company and our parents and subsidiaries. A maximum of 300,000 shares of common stock is available for issuance under the 2019 Plan. As of April 15, 2023, 92,600 shares are available for awards under the 2019 Plan.

 

Employment Agreements with Named Executive Officers

 

With the approval of the Compensation Committee, on June 29, 2022 the Company has entered into written employment agreements with our Chief Executive Officer and Chief Financial Officer. These employment agreements are “at will” and do not provide for a specified term of employment. These employment agreements protect the Company’s interests following termination of employment by prohibiting the executives from disclosing or utilizing the Company’s confidential information, as defined in the agreements, and return of all Company documents.

 

William Koppelmann’s employment agreement with the Company provides for his employment as President, Chief Executive Officer and Chairman of the Board of Directors at an annual base salary of $275,000 for the year ending June 30, 2023, $300,000 for the year ending June 30, 2024, $325,000 for the year ending June 30, 2025, $350,000 for the year ending June 30, 2026 and $375,000 for the year ending June 30, 2027. Mr. Koppelmann is also entitled to a $25,000 bonus paid annually on June 30. The agreement provides for a grant of an Incentive Stock Option Award for 10,000 shares of Company common stock upon execution of the employment agreement. The agreement provides for a performance bonus based on certain performance targets set annually by the Compensation Committee. For the year ended December 31, 2022 the performance was based on the Company’s Consolidated Total Revenue for 2022 and consisted of 20,000 stock options, vesting over two years, expiring five years from issuance. Mr. Koppelmann may participate in all bonus and benefit programs the Company makes available to its employees from time-to-time and for which he is eligible.

 

Brian Krogol’s employment agreement with the Company provides for his employment as Chief Financial Officer at an annual base salary of $175,000 for the year ending June 30, 2023, $200,000 for the year ending June 30, 2024, $225,000 for the year ending June 30, 2025, $250,000 for the year ending June 30, 2026 and $275,000 for the year ending June 30, 2027. Mr. Krogol is also entitled to a $25,000 bonus paid annually on June 30. The agreement provides for a grant of an Incentive Stock Option Award for 10,000 shares of Company common stock upon execution of the employment agreement. The agreement provides for a performance bonus based on certain performance targets set annually by the Compensation Committee. For the year ended December 31, 2022 the performance was based on the Company’s Consolidated Total Revenue for 2022 and consisted of 20,000 stock options, vesting over two years, expiring ten years from issuance. Mr. Krogol may participate in all bonus and benefit programs the Company makes available to its employees from time-to-time and for which he is eligible.

 

With the approval of the Board of Directors, on March 1, 2020 the Company has entered into written employment agreements with our Vice President of Marketing, Victor Galliano, and Vice President of Sales, Robert Mattucci. These employment agreements are “at will” and do not provide for a specified term of employment. These employment agreements protect the Company’s interests following termination of employment by prohibiting the executives from disclosing or utilizing the Company’s confidential information, as defined in the agreements, and return of all Company documents.

 

17 
 

 

COMPENSATION COMMITTEE REPORT

 

The Compensation Committee has reviewed and discussed with management the foregoing description of our Executive Compensation. Based upon this review and discussion, the Compensation Committee recommended to the Board of Directors that such description be included in the Proxy Statement for the Company’s 2023 Annual Meeting of Stockholders.

 

 

  Respectfully submitted,
  Scott Howell, MD
  Christian Hoechner

 

Summary Compensation Table

 

The following table sets forth information concerning the compensation of our chief executive officer, our chief financial officer, and our two other most highly compensated executive officers serving during fiscal 2022 (the “named executive officers”)

 

Name and Principal Position   Year     Salary ($) (1)     Bonus ($) (2)     Option Awards ($) (3)     Total ($)  
William Koppelmann     2022       228,462       10,323       27,770       266,555  
Chief Executive Officer     2021       184,773       9,428       —       194,201  
Brian Krogol     2022       148,077       7,235       28,600       183,912  
Chief Financial Officer     2021       135,385       7,422       —       142,807  
Victor Galliano     2022       175,696       1,701       —       177,397  
Vice President of Sales     2021       163,751       1,703       —       165,454  
Robert Mattucci     2022       147,561       4,679       —       152,240  
Vice President of Marketing     2021       145,588       3,819       —       149,407  

———————
(1) Salary and Commissions paid through payroll
(2) Cash bonuses paid through payroll
(3) Fair Value of Option Awards at Grant Date. See Note 13 to the Company’s Consolidated Financial Statements for the Years Ended December 31, 2022 and 2021 for details on determination of fair value of Stock Options. This amount is calculated assuming that the vesting condition requiring continued employment through June 29, 2024 will be achieved.

 

Outstanding Equity Awards Table

 

The following table sets forth outstanding equity awards for our named executive officers at December 31, 2022.

 

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END

 

Name

  (a)

   Number of
securities
underlying
unexercised
warrants (#)
exercisable
(b)		     Number of
securities
underlying
unexercised
warrants (#)
not exercisable
(c)		     Equity incentive
plan awards:
Number of
securities
underlying
unexercised
unearned
options (#)
(d)		     Option/warrant
exercise price
(e)		     Option/warrant
expiration date
(f)
William Koppelmann     25,000       —       —     $ 4.00     March 31, 2025
      75,000       —       —     $ 12.00     March 31, 2025
      —       —       10,000     $ 4.95     June 28, 2027
Brian Krogol     —       —       83,700     $ 0.80     February 28, 2030
      —       —       10,000     $ 4.50     June 28, 2032
      5,000       —       —     $ 4.00     March 31, 2025
      50,000       —       —     $ 12.00     March 31, 2025
Victor Galliano     —       —       27,900     $ 0.80     February 28, 2030
Robert Mattucci     —       —       27,900     $ 0.80     February 28, 2030

 

The stock options issued under the Equity Incentive Plan vested over a two-year period from the grant date. The warrants all vested upon grant.

 

18 
 

STOCKHOLDER PROPOSALS FOR NEXT ANNUAL MEETING

 

The Company anticipates that it will hold its 2024 Annual Meeting of Stockholders on or about June 21, 2024. Any stockholder of record desiring to submit a proposal for action at the 2024 Annual Meeting of Stockholders and who wishes such proposal to appear in the Company’s Proxy Statement with respect to such meeting should arrange for such proposal to be delivered to the Company’s Corporate Secretary at the address set forth below no later than February 1, 2024 in order to be considered for inclusion in the Company’s proxy statement relating to that meeting. Such proposals also must comply with SEC regulations under Rule 14a-8 regarding the inclusion of stockholder proposals in company-sponsored proxy materials. If you are a beneficial owner of shares held in street name, you can contact the organization that holds your shares for information about how to register your shares directly in your name as a shareholder of record.

 

FINANCIAL INFORMATION AND ANNUAL REPORT ON FORM 10-K

 

The Company’s financial statements for the year ended December 31, 2022 are included in the Company’s 2022 Annual Report to Stockholders, which is available on the Internet at https://standardpremiuminvestors.com.

 

Stockholders may obtain a copy of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 without charge by requesting it in writing from Margaret Ruiz, Corporate Secretary, Standard Premium Finance Holdings, Inc., 13590 SW 134th Avenue, Suite 214, Miami, FL 33186.

 

OTHER MATTERS

 

The Board of Directors is not aware of any other matters to come before the meeting. If any other matter not mentioned in this Proxy Statement is brought before the meeting, the proxy holders named in the enclosed Proxy will have discretionary authority to vote all proxies with respect thereto in accordance with their judgment.

 

         
        By Order of the Board of Directors
May 8, 2023        
        Margaret Ruiz
        Secretary

 

 

19 
 

 

 

 

STANDARD PREMIUM FINANCE HOLDINGS, INC.

THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

annual meeting OF STOCKHOLDERS – jUNE 23, 2023 at 4 PM

        
CONTROL ID:              
REQUEST ID:              
               
             

The undersigned hereby appoints William Koppelmann and Brian Krogol, and each of them, with full power of substitution, as proxies to represent and vote, as designated herein, all shares of Common Stock and Series A Preferred Stock of STANDARD PREMIUM FINANCE HOLDINGS, INC. (the “Company”) which the undersigned would be entitled to vote if personally present at the Annual Meeting of Stockholders of the Company to be held on June 23, 2023 at Three Lakes Clubhouse, 13321 SW 151st Terrace, Miami, Florida 33186 at 4:00 p.m., Eastern Daylight Time, and at any adjournment thereof.

 

In their discretion, the proxies are authorized to vote upon such other matters as may properly come before the meeting or any adjournment thereof.

 

THIS PROXY WILL BE VOTED IN THE MANNER DIRECTED HEREIN. IF NO DIRECTION IS GIVEN, THIS PROXY WILL BE VOTED “FOR” ALL DIRECTOR NOMINEES AND “FOR” PROPOSALS NO. 2 AND 3.

 

The Board of Directors recommends a vote FOR all the nominees listed and FOR Proposals 2 and 3.

   
(CONTINUED AND TO BE SIGNED ON REVERSE SIDE.)
             
             
VOTING INSTRUCTIONS            
If you vote by phone, fax or internet, please DO NOT mail your proxy card.            
             
           

 

 

 

 

 

 

MAIL: Please mark, sign, date, and return this Proxy Card promptly using the enclosed envelope.          
FAX: Complete the reverse portion of this Proxy Card and Fax to 202-521-3464.          
INTERNET: https://www.iproxydirect.com/SPFX          
PHONE: 1-866-752-VOTE(8683)          
               
       
         
         
         
         
                         
 
 

 

ANNUAL MEETING OF THE STOCKHOLDERS OF
STANDARD PREMIUM FINANCE HOLDINGS, INC.		 PLEASE COMPLETE, DATE, SIGN AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE.
PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE: ý
   
PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS  
       
Proposal 1   à FOR

 

WITHHOLD

 

          
  Election of Directors:                  
  01 – William Koppelmann   ¨   ¨          
  02 – Dr. Mark E. Kutner   ¨   ¨       Control ID:  
  03 – Dr. Scott Howell   ¨   ¨       REQUEST ID:  
                     
                     
                     
Proposal 2   à FOR   AGAINST   ABSTAIN      
  To ratify the selection of the independent registered public accounting firm for 2023.   ¨   ¨   ¨      
                     
Proposal 3     FOR   AGAINST   ABSTAIN      
  To approve the issuance of up to 1,400,000 common stock purchase warrants and issuance of up to 1,400,000 shares of common stock upon exercise of such warrants.   ¨   ¨   ¨      
                     
                     
                     
                     
          MARK “X” HERE IF YOU PLAN TO ATTEND THE MEETING: ¨
 

 

 

    

MARK HERE FOR ADDRESS CHANGE ¨ New Address (if applicable):

____________________________
____________________________
____________________________

 

IMPORTANT: Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.

 

Dated: ________________________, 2023

 
  (Print Name of Stockholder and/or Joint Tenant)
 
(Signature of Stockholder)
 
(Second Signature if held jointly)

 

 

 

 

Standard Premium Finance (QX) (USOTC:SPFX)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Standard Premium Finance (QX).
Standard Premium Finance (QX) (USOTC:SPFX)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Standard Premium Finance (QX).